A phase II study of collagen peptide-containing beverage during chemoradiotherapy for patients with head and neck cancer
Phase 2
- Conditions
- head and neck cancer
- Registration Number
- JPRN-UMIN000045594
- Lead Sponsor
- Shizuoka Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
Not provided
Exclusion Criteria
i.Patients who are taking supplement or drugs containing collagen peptide, and who will continue to take them throughout the chemotherapy ii.Patients who will receive palliative chemoradiotherapy iii.Women who are pregnant, contemplating pregnancy or amid breast-feeding iv.Mental disorders which is considered inappropriate for inclusion in the study v.Protein intake restriction vi.Hypersensitivity to the element of V CRESC vii.Unable to take V CRESC per oral viii.Any other cases who are regarded as inadequate for study enrollment by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method